Patents by Inventor Wendi M. David

Wendi M. David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA-cleaving antitumor agents
    Patent number: 6908948
    Abstract: A chemical composition and method of use of the composition is described. The chemical composition includes an aza-enediynes, aza-enyne allenes, or an aza-diallenes. These compound are preferably non-hydrolyzable, cationic compounds that bind to nucleic acids. In addition it is believed that these compounds may undergo chemical reactions in the presence of a nucleic acid to generate reactive intermediates that cleave nucleic acids.
    Type: Grant
    Filed: July 16, 1999
    Date of Patent: June 21, 2005
    Assignee: Research Development Foundation
    Inventors: Sean M. Kerwin, Wendi M. David
  • DNA-cleaving antitumor agents
    Patent number: 6686345
    Abstract: A chemical composition and method of use of the composition is described. The chemical composition includes an aza-enediyne, aza-enyne allene, or an aza-diallene. These compound are preferably non-hydrolyzable, cationic compounds that bind to nucleic acids. In addition it is believed that these compounds may undergo chemical reactions in the presence of a nucleic acid to generate reactive intermediates that cleave nucleic acids.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: February 3, 2004
    Assignee: Research Development Foundation
    Inventors: Sean Michael Kerwin, Wendi M. David
  • DNA-cleaving antitumor agents
    Publication number: 20020132797
    Abstract: A chemical composition and method of use of the composition is described. The chemical composition includes an aza-enediyne, aza-enyne allene, or an aza-diallene. These compound are preferably non-hydrolyzable, cationic compounds that bind to nucleic acids. In addition it is believed that these compounds may undergo chemical reactions in the presence of a nucleic acid to generate reactive intermediates that cleave nucleic acids.
    Type: Application
    Filed: September 28, 2001
    Publication date: September 19, 2002
    Inventors: Sean Michael Kerwin, Wendi M. David
  • DNA-cleaving antitumor agents
    Patent number: 6297284
    Abstract: A chemical composition and method of use of the composition is described. The chemical composition includes an aza-enediyne, aza-enyne allene, or an aza-diallene. These compound are preferably non-hydrolyzable, cationic compounds that bind to nucleic acids. In addition it is believed that these compounds may undergo chemical reactions in the presence of a nucleic acid to generate reactive intermediates that cleave nucleic acids.
    Type: Grant
    Filed: March 23, 2000
    Date of Patent: October 2, 2001
    Assignee: Research Development Foundation
    Inventors: Sean Michael Kerwin, Wendi M. David, Dalip Kumar